Acitretin is an oral retinoid and the active metabolite of etidronate. While most commonly used for the treatment of inflammatory disorders, its indications extend to disorders of keratinization in the paediatric population. In the midst of a safety announcement on the side-effects of isotretinoin by the UK Commission on Human Medicines, a debate on whether acitretin monitoring should also be updated is encouraged.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: